Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition)
LONDON, Oct. 21, 2014 /PRNewswire/ -- Executive Summary
China's regulatory framework for medical devices is undergoing radical changes. The country's new leaders have recognized that the regulations for supervision and administration of medical devices are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest "Regulations for the Supervision and Administration of Medical Devices" on February 12, 2014, which has come into force as of June 1, 2014. Before long, China Food and Drug Administration (hereafter called as CFDA) issued the latest "Measures for the Administration of Medical Device Registration", which has come into force as of October 1, 2014.The overseas medical devices exporting into China market are subject to administration of overall new regulations on medical device registration since October 1, 2014.
In 2009, the Chinese government vigorously launched "China's Health-Care Reform", developed an ambitious blueprint, in which health care system covered about 1.2 billion people by 2011. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. Among them, medical devices represented dynamical growth since 2000s. By 2013, total value of medical devices on Chinese healthcare market has reached 179 billion RMB (about 29 billion US dollars). Medical devices have been widely used in the process of disease prevention, diagnosis, therapy, care and rehabilitation. On the Chinese medical device market, imported medical devices made by overseas and multinational medical device manufacturers account for about a half, in which the high-tech and high-valued medical devices, such as magnetic resonance imaging, CT are almost monopolized by GE, Siemens, Philips and other overseas and multinational companies. It is estimated that Chinese medical device market will be likely to be more than 340 billion RMB (about 57 billion US dollars) by 2015, and will surpass Japan to become the second largest medical device market behind the United States. The Chinese medical device market is one of segment market of the most growth potentiality, which is attracting more and more overseas medical device manufacturers and producers to penetrate such market.
China's radical change of regulatory framework for medical devices brings overseas and multinational medical device manufacturers the maximum challenges and opportunities. Those overseas medical devices have not been granted the certificate of marketing authorization of medical device issued by the government authorities of the country or region of origin have been intercepted outside the door of Chinese clinical trial market not only, and be blocked outside the door of Chinese medical device market also. Nonetheless, Chinese authorities relaxed the admittance license of overseas medical devices. The overseas medical device manufacturer exporting Class I medical devices into China only need to file the archives and the certificate of marketing authorization of the government authorities of the country or region of origin to the CFDA for recordation. The overseas medical device manufacturer exporting Class II and Class III medical devices into China should be subject to be examined and approved by the CFDA. The Chinese authorities will strengthen the supervision and administration for medical devices, including their registration, production, distribution and use. How do you in compliance with the latest Chinese regulations on medical devices? How do you operate business smoothly in China? How do you conduct the clinical evaluation and clinical trial for your products exporting into the Chinese market?
The Chinese concept of clinical evaluation and clinical trial for medical device registration is unique, which is distinct from the clinical trial in U.S. and EU countries.
In China, the process of application and approval for clinical evaluation and clinical trial of imported medical device registration is very complex, because the Chinese medical device authorities administer and control this process by exorbitant administrative measures and regulations, even the guidances. Moreover, these exorbitant administrative measures and regulations, and the guidances are variable and lack of transparency. In addition, the cultural difference between China and Western countries as well as the language barriers will increase the challenge faced by overseas and multinational medical device manufacturers and producers.
To enter such a lucrative medical device market, overseas and multinational medical device manufacturers must have a comprehensive and thorough knowledge of the latest Chinese regulations on medical device clinical evaluation and clinical trial. Otherwise, the restrictive legal requirements and approval delays eat up your development time and budget.
Latest Guidebook for Conducting Medical Device Clinical Evaluation and Clinical Trial in China: From Regulations to Practices (2014 Edition) not only provided a comprehensive and thorough knowledge of the latest Chinese regulations on clinical evaluation and clinical trial for imported medical device registration but also introduced the practical operation how to comply with the Chinese GCP to guide you use the Chinese trial venues to keep medical device development lean and achieve a successful approval for your products entry into the Chinese medical device market.
The organizations of this guidebook are arranged as follows. Chapter 2 introduces the framework of the latest Chinese applicable regulations for clinical evaluation and clinical trial of medical device registration to provide a comprehensive and thorough knowledge of the latest Chinese regulations for clinical evaluation and clinical trial of medical device registration. Chapter 3 provides a comprehensive comparative analysis to tell overseas medical device manufacturer what Chinese regulations on medical device registration are undergoing radical changes, from what Chinese regulations on imported medical device registration are undergoing radical changes to what overseas medical devices need to conduct the clinical evaluation or clinical trial for imported medical device registration. Chapter 4 provides an overview of the Chinese regulatory authorities -- China Food and Drug Administration (CFDA) being responsible for application and approval for clinical evaluation and clinical trial of imported medical device registration to give the direction of gateway for application for approval of clinical trial of imported overseas medical device registration. Chapter 5 elaborates the knowledge preparation before consucting the clinical evaluation and clinical trial for imported medical device registration to let overseas medical device manufacturer understand the unique Chinese approach for medical device registration and lay the knowledge foundation for the practical operation. Chapter 6 elaborates the medical device classification to let overseas medical device manufacturer understand the Chinese medical device classification, because the imported overseas medical device registration must be in compliance with such classification of medical devices. Chapter 7 introduces the rights of human subjects and every party's responsibilities in clinical trials for imported overseas medical devices in China. Chapter 8 introduces the unique Chinese regulations for clinical evaluation and clinical trial of imported medical device registration to help overseas medical device manufacturers to remove their confusion. Chapter 9 provides the practical guidance for applying for clinical trials of imported
overseas medical device registration, from what imported overseas medical devices need to conduct clinical trial and approval within chinese territory, how to apply for clinical trial of imported overseas medical device registration, how to compile the product technical requirements, how to compile application documents to how to acquire the approval document for clinical trial of imported overseas medical device registration to smoothly navigate complex regulatory requirements step by step. Chapter 10 provides the practical guidance for conducting clinical evaluation of imported overseas medical device registration, also from what imported overseas medical devices need to conduct clinical evaluation of imported overseas medical device registration, what requirements are for conducting clinical evaluation of imported overseas medical device registration, how to conduct the clinical evaluation of imported overseas medical device registration to how to compile application documents to smoothly navigate complex regulatory requirements step by step. Chapter 11 Appendices provide a complete set of full text in English of the latest Chinese applicable regulations for medical device clinical evaluation and clinical trial of imported overseas medical device registration, which include "Regulations for the Supervision and Administration of Medical Devices (2014 Edition)", "Measures for the Administration of Medical Device Registration (2014 Edition)", "Regulations on the Administration of the Instructions and Labels of Medical Devices (2014 Edition)", "Rules for Medical Device Classification (2014 Edition)" , "Provisions for Clinical Trials of Medical Devices" and "Technical Guidance Principles for Clinical Evaluation of Medical Devices".
The audiences of this guidebook are overseas medical device manufacturers wishing to enter into the Chinese medical device market, and multinational medical device companies have penetrated into the Chinese medical device market, and their senior executive officers engaging in regulatory affairs expecting to understand how to smoothly conduct clinical evaluation and clinical trial for their medical device product registration in China, and how to comply with the Chinese GCP.
After having skimmed through this guidebook, audiences can clearly acquire not only a comprehensive and thorough knowledge of latest Chinese regulations on clinical evaluation and clinical trial for imported overseas medical device registration but also the practical operation how to comply with the Chinese GCP, how to conduct the clinical evaluation and clinical trial for imported overseas medical device registration. Access China Management Consulting Ltd hopes this guidebook, based on full and accurate laws and regulations, can guide overseas and multinational medical device manufacturers and producers to achieve a successful entry into the Chinese medical device market, and smoothly operate the clinical evaluation and the clinical trial for their products in China.
Download the full report: https://www.reportbuyer.com/product/2432023/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/latest-guidebook-for-conducting-medical-device-clinical-evaluation-and-clinical-trial-in-china-from-regulations-to-practices-2014-edition-809155739.html
SOURCE ReportBuyer
Share this article